These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3754967)

  • 21. Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease.
    Gopinath B; Musselman R; Beard N; El-Kaissi S; Tani J; Adams CL; Wall JR
    Clin Exp Immunol; 2006 Jul; 145(1):56-62. PubMed ID: 16792674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pathogenesis of autoimmune thyroiditis and diffuse toxic goiter].
    Balabolkin MI
    Sov Med; 1980; (8):82-5. PubMed ID: 6893498
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinico-diagnostic significance of autoimmune reactions in patients with cranio-cerebral injury].
    Livshits LIa; Shakarova GG
    Vopr Neirokhir; 1975; (4):33-7. PubMed ID: 1162940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunopathology in craniocerebral trauma].
    Ermekov ZhM
    Zh Vopr Neirokhir Im N N Burdenko; 1997; (2):23-5. PubMed ID: 9235830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interactions between serum antibodies of patients with autoimmune thyropathies and isolated cells of diffuse toxic euthyroid nodular goiter].
    Kraĭnova SI; Kandror VI
    Probl Endokrinol (Mosk); 1993; 39(6):46-50. PubMed ID: 8290513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyrotoxic autoimmune encephalopathy: a repeat positron emission tomography study.
    Seo SW; Lee BI; Lee JD; Park SA; Kim KS; Kim SH; Yun MJ
    J Neurol Neurosurg Psychiatry; 2003 Apr; 74(4):504-6. PubMed ID: 12640074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [ T- and B-lymphocyte populations in thyroid pathology].
    Artemova EP; Nikolaev AI
    Probl Endokrinol (Mosk); 1980; 26(1):25-7. PubMed ID: 6965789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Indicators of the autoimmune component in newborn infants with pathology of the central nervous system].
    Ivanova OV; Autenshlius AI
    Pediatriia; 1989; (9):110. PubMed ID: 2587157
    [No Abstract]   [Full Text] [Related]  

  • 29. Further studies on thyroid growth-stimulating immunoglobulins in euthyroid nonendemic goiter.
    van der Gaag RD; Drexhage HA; Wiersinga WM; Brown RS; Docter R; Bottazzo GF; Doniach D
    J Clin Endocrinol Metab; 1985 May; 60(5):972-9. PubMed ID: 2858493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders.
    Mori T; Kriss JP
    J Clin Endocrinol Metab; 1971 Oct; 33(4):688-98. PubMed ID: 5109861
    [No Abstract]   [Full Text] [Related]  

  • 31. [Autoimmunization and neutrophil functional indices in the surgical treatment of diffuse toxic goiter].
    Radomskiĭ VT
    Vestn Khir Im I I Grek; 1981 May; 126(5):57-60. PubMed ID: 6894987
    [No Abstract]   [Full Text] [Related]  

  • 32. Heterogeneity of autoantibodies against thyroid peroxidase in autoimmune thyroid disease: evidence against antibodies directly inhibiting peroxidase activity as regulatory factors in thyroid hormone metabolism.
    Saller B; Hörmann R; Mann K
    J Clin Endocrinol Metab; 1991 Jan; 72(1):188-95. PubMed ID: 1702446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoimmune model of schizophrenia with special reference to antibrain antibodies.
    Pandey RS; Gupta AK; Chaturvedi UC
    Biol Psychiatry; 1981 Dec; 16(12):1123-36. PubMed ID: 6186298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunological and morphological comparisons in toxic goiter].
    Livergant IuE; Iakimov TP; Duma VA; Mikulinskiĭ IuE; Tarikovskaia NG
    Probl Endokrinol (Mosk); 1980; 26(1):20-4. PubMed ID: 6987641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Frequency of antithyroid autoantibodies in the hyperthyroid syndrome].
    Pencea V; Jacotă L; Ionescu A; Popescu C
    Rev Med Chir Soc Med Nat Iasi; 1968; 72(3):615-20. PubMed ID: 4971959
    [No Abstract]   [Full Text] [Related]  

  • 36. [Autoimmune processes in toxic goiter].
    Evko AG
    Klin Khir (1962); 1973 Dec; 12():19-23. PubMed ID: 4801827
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cytologic differentiation between the autonomous and autoimmune type of diffuse hyperthyroid goiter: correlation with TSH receptor antibodies, microsomal antibodies and infiltrative ophthalmopathy].
    Smoje J; Bistrović D; Ugrai V; Gall D
    Lijec Vjesn; 1989 Dec; 111(12):437-9. PubMed ID: 2636304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Characteristics of immunological reactivity of patients with diffuse toxic goiter in relation to the duration of the disease].
    Aliev TA; Nasibov AI
    Probl Endokrinol (Mosk); 1986; 32(3):7-10. PubMed ID: 3755533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between thyroid autoimmunity and Yersinia enterocolitica antibodies.
    Corapçioğlu D; Tonyukuk V; Kiyan M; Yilmaz AE; Emral R; Kamel N; Erdoğan G
    Thyroid; 2002 Jul; 12(7):613-7. PubMed ID: 12193307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decrease of immunoglobulin G-Fc receptor-bearing T lymphocytes in Graves' disease.
    Mori H; Amino N; Iwatani Y; Asari S; Izumiguchi Y; Kumahara Y; Miyai K
    J Clin Endocrinol Metab; 1982 Sep; 55(3):399-402. PubMed ID: 6178751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.